SCHEMBL798244

SCHEMBL798244

Nc1cc(CN2CCOCC2)cc(Cl)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.49
MAPT P10636 4/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
NCF1 P14598 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
JAK2 O60674 1/20 0.44
CXCR4 P61073 1/20 0.42
CYP2A13 Q16696 3/20 0.42
PIK3CA P42336 1/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
HIF1A Q16665 1/20 0.40
EPAS1 Q99814 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL793723 0.89 HRH3 (0.52) HRH3MAPTNCF1SMN1; SMN2JAK2
SCHEMBL793450 0.89 HRH3 (0.56) HRH3MAPTCYP1A2CYP2D6NCF1
SCHEMBL29632675 0.81 NCF1 (0.45) HRH3MAPTNCF1SMN1; SMN2JAK2
SCHEMBL20908819 0.81 CNR2 (0.51) HRH3MAPTNCF1SMN1; SMN2CXCR4
SCHEMBL31703161 0.78 NCF1 (0.42) HRH3MAPTNCF1SMN1; SMN2JAK2
SCHEMBL31703257 0.78 HRH3 (0.45) HRH3MAPTNCF1SMN1; SMN2CXCR4
SCHEMBL19229780 0.75 SMN1; SMN2 (0.51) HRH3MAPTCYP1A2CYP2D6NCF1
SCHEMBL6033570 0.75 CXCR4 (0.49) HRH3MAPTCYP1A2CYP2D6SMN1; SMN2
SCHEMBL797884 0.75 GAA (0.47) SMN1; SMN2CYP2A13KDM4ETSHRALDH1A1
SCHEMBL797883 0.75 GAA (0.47) SMN1; SMN2CYP2A13KDM4ETSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4112617-A1 METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES Daewoong Pharmaceutical Co., Ltd. (KR) 2023-01-04 EP disclosed
WO-2012035055-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-22 WO disclosed
WO-2012035055-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-22 WO disclosed
WO-2011110575-A1 DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2011-09-15 WO disclosed